NasdaqGM - Delayed Quote USD

Avidity Biosciences, Inc. (RNA)

Compare
45.65 +1.02 (+2.29%)
At close: 4:00 PM EDT
46.30 +0.65 (+1.42%)
After hours: 6:50 PM EDT
Advanced Chart
Loading Chart for RNA
DELL
  • Previous Close 44.63
  • Open 45.57
  • Bid 45.63 x 300
  • Ask 45.78 x 500
  • Day's Range 45.06 - 46.08
  • 52 Week Range 4.82 - 48.80
  • Volume 2,691,623
  • Avg. Volume 1,468,034
  • Market Cap (intraday) 5.397B
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) --
  • EPS (TTM) -2.95
  • Earnings Date Nov 6, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 66.80

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

www.aviditybiosciences.com

253

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Avidity Biosciences, Inc.

Recent News: RNA

View More
View More

Performance Overview: RNA

Trailing total returns as of 9/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RNA
404.42%
S&P 500
19.79%

1-Year Return

RNA
555.89%
S&P 500
28.29%

3-Year Return

RNA
90.53%
S&P 500
28.89%

5-Year Return

RNA
72.26%
S&P 500
87.87%

Compare To: RNA

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

RNA
Avidity Biosciences, Inc.
45.65
+2.29%
Mkt Cap 5.397B
Industry Biotechnology
SLNO
Soleno Therapeutics, Inc.
52.73
-1.53%
Mkt Cap 2.05B
Industry Biotechnology
JANX
Janux Therapeutics, Inc.
49.98
+3.44%
Mkt Cap 2.607B
Industry Biotechnology
DYN
Dyne Therapeutics, Inc.
36.41
+6.03%
Mkt Cap 3.656B
Industry Biotechnology
ADMA
ADMA Biologics, Inc.
19.74
+2.17%
Mkt Cap 4.601B
Industry Biotechnology
APGE
Apogee Therapeutics, Inc.
52.95
-0.73%
Mkt Cap 3.001B
Industry Biotechnology
RYTM
Rhythm Pharmaceuticals, Inc.
54.55
+1.70%
Mkt Cap 3.335B
Industry Biotechnology
VERA
Vera Therapeutics, Inc.
41.99
+4.12%
Mkt Cap 2.302B
Industry Biotechnology
ASND
Ascendis Pharma A/S
153.43
+3.06%
Mkt Cap 8.799B
Industry Biotechnology
CORT
Corcept Therapeutics Incorporated
40.92
-3.19%
Mkt Cap 4.276B
Industry Biotechnology
NUVL
Nuvalent, Inc.
103.25
+0.60%
Mkt Cap 7.207B
Industry Biotechnology

Statistics: RNA

View More

Valuation Measures

Annual
As of 9/18/2024

  • Market Cap

    5.28B

  • Enterprise Value

    3.99B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    362.59

  • Price/Book (mrq)

    4.32

  • Enterprise Value/Revenue

    376.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -18.20%

  • Return on Equity (ttm)

    -28.36%

  • Revenue (ttm)

    10.6M

  • Net Income Avi to Common (ttm)

    -252.45M

  • Diluted EPS (ttm)

    -2.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.3B

  • Total Debt/Equity (mrq)

    0.69%

  • Levered Free Cash Flow (ttm)

    -109.55M

View More

Research Analysis: RNA

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

51.00
66.80 Average
45.65 Current
96.00 High
 
View More

Company Insights: RNA

People Also Watch

RVMD Revolution Medicines, Inc.
46.18
+4.81%
 
PLRX Pliant Therapeutics, Inc.
12.62
+0.96%
 
AKRO Akero Therapeutics, Inc.
28.00
+3.86%
 
PCVX Vaxcyte, Inc.
117.12
+0.50%
 
STOK Stoke Therapeutics, Inc.
15.14
-0.53%
 
NKTX Nkarta, Inc.
5.38
+2.09%
 
KYMR Kymera Therapeutics, Inc.
49.03
+5.58%
 
FDMT 4D Molecular Therapeutics, Inc.
13.50
-19.74%
 
BDTX Black Diamond Therapeutics, Inc.
4.7800
+1.06%
 
CABA Cabaletta Bio, Inc.
4.7000
+4.91%
 
RLAY Relay Therapeutics, Inc.
7.86
+3.69%
 
CRNX Crinetics Pharmaceuticals, Inc.
53.88
+2.10%
 
GBIO Generation Bio Co.
2.8600
+10.42%
 
ARQT Arcutis Biotherapeutics, Inc.
10.14
-2.50%
 
NRIX Nurix Therapeutics, Inc.
25.06
+1.29%
 
ALEC Alector, Inc.
6.14
+8.87%